Metabolomics

Dataset Information

0

The nasal microbiome and metabolites are altered in depression patients


ABSTRACT: Depressive disorder is a heterogeneous neuropsychiatric disorder. It affects millions of people worldwide. The exact causes of depressive behavior remain unclear and are believed to implicate both genetic and environmental factors. In the past decade, there have been numerous studies on the dysbiosis of gut microbiota in patients with depression and animal models. Of particular note is the role of gut brain axis regulation, in which a series of continuously expanding microbial metabolites, including short chain fatty acids and neurotransmitters, have been identified as signaling molecules that affect behavioral outcomes. However, most insights about the association between microbiota and depression still focus on the gut-brain axis and ignore that nasal microbiota could form a complex and essential link with the nervous system via the nose-to-brain pathway. So far, the potential influence of the nasal microbiome on neurological disorders has been largely overlooked. We investigated the impact of nasal microbiota and nasal metabolites on depression in this study.

INSTRUMENT(S): Liquid Chromatography MS - negative - reverse phase, Liquid Chromatography MS - positive - reverse phase

PROVIDER: MTBLS10742 | MetaboLights | 2025-07-21

REPOSITORIES: MetaboLights

Dataset's files

Source:
Action DRS
H100.mzXML Mzxml
H103.mzXML Mzxml
H105.mzXML Mzxml
H110.mzXML Mzxml
H113.mzXML Mzxml
Items per page:
1 - 5 of 166

Similar Datasets

2021-12-31 | GSE189159 | GEO
2021-12-31 | GSE189233 | GEO
2021-03-09 | PXD022577 | Pride
2025-09-24 | GSE291874 | GEO
2019-04-05 | GSE129359 | GEO
2024-06-21 | GSE178571 | GEO
2024-04-01 | GSE229237 | GEO
2019-07-16 | PXD012736 | Pride
| PRJNA666980 | ENA
2026-02-12 | GSE289419 | GEO